Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05693714
Other study ID # Adenovirus infection
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date January 20, 2023
Est. completion date December 31, 2025

Study information

Verified date December 2022
Source Assiut University
Contact Rana Refaat
Phone 01016846749
Email 14223863@med.aun.edu.eg
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Adenoviruses have been linked to severe hepatitis in children. They are non-enveloped, icosahedral viruses of medium size (90-100 nm) (5). Adenoviruses usually infect the respiratory tract, eyes, urinary tract, intestines, and central nervous system (6). These diseases are


Description:

Hepatitis is an inflammatory reaction of the liver that lead to a spectrum of health problems (1). Hepatitis results from a variety of causes, both infectious and non-infectious. Infectious agents include viruses and parasites. Non-infectious causes include drugs and toxic agents (2). Viral hepatitis remains an important challenge to human health, making it a leading cause of death globally. The absolute burden of viral hepatitis is increasing gradually (3). The most common types of viral hepatitis are hepatitis A, B, and C. The other types are hepatitis D and E, which are less frequent (2). Epstein-Barr virus (EBV) and cytomegalovirus (CMV) infections are common and are associated with liver manifestations (4). Adenoviruses have been linked to severe hepatitis in children. They are non-enveloped, icosahedral viruses of medium size (90-100 nm) (5). Adenoviruses usually infect the respiratory tract, eyes, urinary tract, intestines, and central nervous system (6). These diseases are generally self-limiting, but severe infections can occur in immunocompromised hosts (7). Children are more susceptible to HAdVs infection because their immune systems are less developed. HAdVs cause a range of symptoms, including colds, vomiting, diarrhea, and sometimes pneumonia, but rarely hepatitis in immunocompromised patients (8) In April 2022, the WHO has reported severe acute hepatitis outbreaks among children from 11 countries across Europe and America, which have induced great public concern, HAdV is presumed to be a possible etiology of this outbreak (9). The diagnostic methods for adenovirus include antigen detection, polymerase chain reaction (PCR), virus isolation, and serology (10).


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 76
Est. completion date December 31, 2025
Est. primary completion date December 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - All children who are presented with symptoms suggestive of acute hepatitis like clinical jaundice, in the form of yellowish discoloration on sclera, fever, abdominal pain, diarrhea and raised liver enzymes between age group 2 years and 16 years. Exclusion Criteria: - -All patients under 2 years old and above 16 years. - History of drug intake which may affect liver functions

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Pcr
Polymerase chain reaction

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Outcome

Type Measure Description Time frame Safety issue
Primary Adenovirus infection Prevalence of adenovirus infection in children with autoimmune hepatitis 2024
Primary Adenovirus infection Prevalence of adenovirus infection in children with autoimmune hepatitis 2025
See also
  Status Clinical Trial Phase
Not yet recruiting NCT01168570 - Progression of Renal Amyloidosis of FMF and Relation to Serum SAA Level N/A
Completed NCT03548753 - Use of FFR-CT in Stable Intermediate Chest Pain Patients With Severe Coronary Calcium Score
Completed NCT03138772 - Tracking CF Lung Disease Through the Early Years: Utility of the LCI
Completed NCT00233649 - DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European Guidelines Phase 4
Completed NCT06433154 - Arthroscopy of the Temporomandibular Joint. On Jaw Mobility, Pain and HRQoL
Not yet recruiting NCT06448715 - Real-World Treatment Study of Soliris (Eculizumab)
Recruiting NCT03728829 - Targeted Next Generation Sequencing for the Efficacy of Trastuzumab Neoadjuvant Chemotherapy in Breast Cancer
Completed NCT00745966 - Atypical Antipsychotics in Improvement of Quality of Life in Bipolar Disorder N/A
Recruiting NCT03253536 - Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma N/A
Completed NCT02922205 - Stapler Post-market Observational Study